Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions

BACKGROUND: Increasingly, patients are expected to influence decisions previously reserved for regulatory agencies, pharmaceutical companies, and healthcare professionals. Individual patients have previously represented their patient population when rare, serious adverse events (AEs) were weighed as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sachs, Mikkel Lindskov, Sporrong, Sofia Kälvemark, Colding-Jørgensen, Morten, Frokjaer, Sven, Helboe, Per, Jelic, Katarina, Kaae, Susanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539258/
https://www.ncbi.nlm.nih.gov/pubmed/28824274
http://dx.doi.org/10.1007/s40290-017-0200-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539258/
https://www.ncbi.nlm.nih.gov/pubmed/28824274
http://dx.doi.org/10.1007/s40290-017-0200-z

Ejemplares similares